Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00143780Phase 4Completed
Phase 4, randomised trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection (2 arms), sponsored by University Health Network. Primary endpoint: Immunogenicity of two vaccines via serotype specific capsular antibody formation and functional antibody formation. Started May 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00143780.